← Back to Clinical Trials
Recruiting NCT07574567

NCT07574567 Familia Imara: A Parenting Program to Reduce Family Violence in Tanzania

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07574567
Status Recruiting
Phase
Sponsor Saini Das
Condition Intimate Partner Violence (IPV)
Study Type INTERVENTIONAL
Enrollment 6,216 participants
Start Date 2026-05-02
Primary Completion 2027-05-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Familia Imara

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 6,216 participants in total. It began in 2026-05-02 with a primary completion date of 2027-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This cluster-randomized controlled trial will evaluate the effectiveness, implementation, and scalability of Familia Imara, a group-based, couples-focused, community health worker (CHW)-delivered parenting program, on reducing intimate partner violence (IPV), harsh discipline, and improving child development and nutrition outcomes in the Mara and Geita regions of Tanzania. Villages will be randomly assigned to either an intervention or control arm. The study will be implemented in two sequential cohorts. In Cohort 1, a traditional randomized controlled trial will compare intervention villages receiving the program to control villages receiving no intervention (waitlist control), with delivery supported primarily by implementing partners in collaboration with government supervisors. In Cohort 2, the same villages will retain their original assignment. Intervention villages will receive the program under a government-led delivery model to assess scalability and integration into existing systems, while control villages will transition from waitlist to receive the intervention. Evidence generated will inform policy and practice for preventing family violence and promoting early childhood development at scale.

Eligibility Criteria

Inclusion Criteria: * The household has a child aged 0-24 months at enrollment * The child has a primary female caregiver (i.e., mother) and a primary male caregiver (i.e., father) who are in a partnered relationship * Primary female caregiver, primary male caregiver, and child reside together in the same household * Both caregivers provide written informed consent for themselves and their child to participate in the study Exclusion Criteria: * Need to satisfy the inclusion criteria * Expecting to relocate in the next year

Contact & Investigator

Central Contact

Joshua Jeong, ScD

✉ joshua.jeong@emory.edu

📞 404-727-2671

Frequently Asked Questions

Who can join the NCT07574567 clinical trial?

This trial is open to participants of all sexes, studying Intimate Partner Violence (IPV). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07574567 currently recruiting?

Yes, NCT07574567 is actively recruiting participants. Contact the research team at joshua.jeong@emory.edu for enrollment information.

Where is the NCT07574567 trial being conducted?

This trial is being conducted at Dar es Salaam, Tanzania.

Who is sponsoring the NCT07574567 clinical trial?

NCT07574567 is sponsored by Saini Das. The trial plans to enroll 6,216 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology